What is Menicon Co Ltd (MECNY)?

Menicon Co Ltd (MECNY) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of MECNY?

The current price of MECNY is $88.63. Prices are updated in real time on Stocks360.

What is MECNY's price-to-earnings (PE) ratio?

MECNY's trailing twelve-month PE ratio is 19.13, based on current price and earnings per share data available on Stocks360.

What is MECNY's market capitalization?

MECNY's market capitalization is $26,874,663,708.00, placing it in the large-cap tier.

Does MECNY pay a dividend?

Yes. MECNY has a trailing twelve-month dividend yield of 0.02%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Menicon Co Ltd (MECNY)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

$88.63

Market Cap

$26.87B

PE (TTM)

19.13

EPS (TTM)

N/A

Dividend Yield

1.52%

Beta

0.15

Day Range

$88.63 – $88.63

52-wk Range

$88.63 – $88.63

Avg Volume

N/A

Volume

100.00

Menicon Co Ltd (MECNY) is a publicly traded company in the Healthcare sector. Latest price: $88.63. Market cap $26.87B. Trailing PE 19.13. Dividend yield 1.52%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $88.63 2026-04-06 · $88.63 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Menicon Co Ltd

Menicon Co Ltd operates as a specialized manufacturer within the contact lens industry. Its operations involve the worldwide manufacturing, distribution, and trade (both export and import) of contact lenses, in addition to other medical merchandise. The company also produces and sells medical instruments, supplies various medical provisions, and is actively engaged in the research and development of intraocular lenses. Its diverse product portfolio prominently includes soft contact lenses, rigid gas permeable lenses, and a range of lens care products.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	19.13×
P/S (TTM)	1.07×
P/B	1.42×
PEG	0.35×
P/FCF (TTM)	0.00×
EV / EBITDA	8.03×
EV / Sales	1.44×
Earnings Yield	5.23%
Free Cash Flow Yield	0.00%
Dividend Yield	1.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$184.26B
Revenue (TTM)	$127.73B
Net Income (TTM)	$7.15B
Free Cash Flow (TTM)	$566.91M
Net Debt	$47.48B
Working Capital	$47.72B
Gross Margin	54.06%
Operating Margin	9.16%
Net Margin	5.60%
Return on Equity	7.70%
Return on Invested Capital	4.45%